Immedia Broadcasting plc
27 June 2005
27 June 2005
Immedia Broadcasting
Lloydspharmacy, first company to sign up for Radiovision
Immedia Broadcasting plc, the live in-store radio pioneer is pleased to announce
that Lloydspharmacy, the UK's largest community pharmacy operator is to launch '
Radiovision' in six of its leading pharmacies around the country for an initial
three-month trial.
'Radiovision' is Immedia's latest revolutionary product. It innovatively
combines live in-store radio with synchronised video content tailored for retail
environments. Lloydspharmacy is the first major retailer to trial 'Radiovision'
since its first public demonstration at the London Multi Channel Retail show in
March this year.
Immedia already broadcasts its highly successful tailored radio service '
Lloydspharmacy Live!' across the 1400 Lloyds pharmacies. The live radio station
is a powerful communication tool for both staff and customers in regards to
healthcare messages and has driven incremental sales. It provides live and
interactive radio, which entertains and engages staff and consumers in an
up-to-the-minute way that pre-recorded content does not.
With 'Radiovision', Immedia continues to find innovative ways to educate and
market products and services. Through this unique and impressive technology,
radio works in unison with plasma screens to engage consumers and explain
products and services in greater detail, as well as provide current affairs,
music and personality. The specially consolidated video content can be instantly
triggered by presenters when they explain products or services. In this way '
Radiovision' will educate customers on key health messages such as allergy and
suncare and reinforce brand awareness in the best and friendliest way ever used
in retail.
Bruno Brookes, CEO of Immedia commented: 'We have had an excellent relationship
with Lloydspharmacy since launching their tailored Live radio station two years
ago. The sales uplift demonstrated has been positive and we are very pleased
that they are the first retailer to benefit from Radiovision. This combination
of radio and vision is extremely powerful and particularly relevant to retail
environments where customers need to be advised and guided such as in a
pharmacy. We look forward to developing this next generation in-store medium
with Lloydspharmacy.'
Mark Green, Commercial Director, Lloydspharmacy said: 'We are very excited to
be working with Immedia Broadcasting and to be part of this innovative trial.
Lloydspharmacy Live has been hugely popular and extremely successful. We hope by
introducing the Radiovision concept this will enhance even further our product
and service offering to customers and reinforce our standing as the largest
community pharmacy chain in the UK.'
For further information please contact:
Immedia Broadcasting Plc
Bruno Brookes, Chief Executive 01635 572 800
gcg hudson sandler
Nick Lyon / Sandrine Gallien 020 7796 4133
Lloydspharmacy
Ann Bryant, Starfish Communications 020 7323 2121
Notes to editors:
Immedia Broadcasting PLC creates live, tailored radio stations for major
retailers. These stations engage and educate staff and customers and have
proved to be a powerful and instantly flexible media channel to drive sales.
Existing stations are:
• 'Impulse Live', the largest in-store media channel currently reaching 20
million shoppers a week across 5000 convenience stores for:
- Texaco
- Londis
- Mills
- Costcutter
- Spar
- Star News
• 'LloydsPharmacy Live', broadcast to the largest community pharmacy
operator in the UK;
• 'HSBC Live', broadcast to 400 branches in the UK;
• 'Dixons Live' broadcast to more than 200 Dixons' stores;
• 'Vitus Apotek', broadcast in Norwegian to pharmacy retail stores in
Norway.
Lloydspharmacy is the largest community pharmacy chain in the UK, with 1,400
pharmacies located nationwide. Lloydspharmacy is part of the Admenta UK plc
group, which is owned by Celesio AG.
For more information visit www.lloydspharmacy.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.